AIRSCULPT TECHNOLOGIES INC (AIRS) competitors & alternatives
Health Care · NASDAQ
AIRSCULPT TECHNOLOGIES INC (AIRS)'s top competitors and alternatives — its most similar public companies — include Apyx Medical Corp (APYX), CONMED CORP (CNMD), STEREOTAXIS INC (STXS), KAILERA THERAPEUTICS INC (KLRA), ATRICURE INC (ATRC), Lilly (Eli) (LLY), CLEARPOINT NEURO INC (CLPT), Viking Therapeutics (VKTX), Microbot Medical Inc. (MBOT), SIGHT SCIENCES INC (SGHT), SI BONE INC (SIBN) and CORBUS PHARMACEUTICALS HOLDINGS IN (CRBP). These are AIRSCULPT TECHNOLOGIES INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top AIRS competitors & alternatives
-
Apyx Medical CorpAPYXHealth Care
Apyx Medical provides advanced helium plasma-based surgical technology for cosmetic body contouring and hospital-based electrosurgical procedures.
$3.91 (as of 2026-07-22) · market cap $163M
-
CONMED CORPCNMDHealth Care
CONMED makes surgical visualization, insufflation, and monitoring devices that enable surgeons to perform minimally invasive procedures more effectively and…
$42.00 (as of 2026-07-22) · market cap $1.3B
-
STEREOTAXIS INCSTXSHealth Care
Stereotaxis develops robotic magnetic navigation systems for minimally invasive interventional procedures in cardiology, electrophysiology, and vascular…
$1.49 (as of 2026-07-22) · market cap $147M
-
KAILERA THERAPEUTICS INCKLRAHealth Care
A clinical-stage biotech developing a diversified pipeline of GLP-1-based obesity management drugs, led by a dual GLP-1/GIP agonist injectable designed to…
$17.79 (as of 2026-07-22) · market cap $2.4B
-
ATRICURE INCATRCHealth Care
AtriCure is a leading surgical device company treating atrial fibrillation and post-operative pain through minimally invasive cardiac ablation and cryotherapy…
$33.52 (as of 2026-07-22) · market cap $1.7B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,163.01 (as of 2026-07-22) · market cap $1.09T
-
CLEARPOINT NEURO INCCLPTHealth Care
ClearPoint Neuro develops real-time imaging-guided stereotactic systems for minimally invasive brain surgery and intracranial drug delivery.
$15.03 (as of 2026-07-22) · market cap $453M
-
Viking TherapeuticsVKTXHealth Care
Viking is developing VK2735, a novel dual GLP-1/GIP receptor agonist in Phase 3 trials for obesity and metabolic disorders, targeting a high-growth market…
$37.31 (as of 2026-07-22) · market cap $4.3B
-
Microbot Medical Inc.MBOTHealth Care
Microbot Medical is an early-stage medical device company developing next-generation robotic endoluminal surgical systems for minimally invasive interventional…
$1.77 (as of 2026-07-22) · market cap $119M
-
SIGHT SCIENCES INCSGHTHealth Care
Sight Sciences develops minimally invasive interventional devices for glaucoma and dry eye, targeting ophthalmology markets through reimbursement-focused…
$5.03 (as of 2026-07-22) · market cap $274M
-
SI BONE INCSIBNHealth Care
SI-BONE is a medical device company providing minimally invasive surgical solutions to treat conditions of the sacroiliac joint and spinopelvic anatomy.
$16.71 (as of 2026-07-22) · market cap $744M
-
CORBUS PHARMACEUTICALS HOLDINGS INCRBPHealth Care
Clinical-stage biopharmaceutical company developing next-generation antibody drug conjugates for oncology and a CB1 receptor inverse agonist for obesity.
$8.84 (as of 2026-07-22) · market cap $163M
Not quite? Describe exactly what you want →
Peers are AIRSCULPT TECHNOLOGIES INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: AIRSCULPT TECHNOLOGIES INC (AIRS).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.